HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Chamberlain, J. J. Articles by Small, D. PubMed Articles by Chamberlain, J. J. Articles by Small, D. Social Bookmarking                What's this?

Successful Use of a Single Subcutaneous Continuous Glucose Monitor Sensor for 28 Days in a Patient with Type 1 Diabetes

The first 20% of the full text of this article appears below.

	PRESENTATION

 
R.F. is a 48-year-old white man with type 1 diabetes since age 24. He was initially seen at the Utah Diabetes Center in Salt Lake City on 15 September 2006. The patient had been treated with NPH insulin, 2 units at bedtime; ultralente insulin, 3 units twice a day; and lispro insulin, 2-3 units at each meal. The patient corrected elevated blood glucose levels with 1 unit of lispro for blood glucose readings > 200 mg/dl and about 2 units of lispro for blood glucose readings > 300 mg/dl. His hemoglobin A1c (A1C) was 9.2%, and he described losing control of his diabetes progressively through the years.

The patient often developed nocturnal hypoglycemia, most likely as a result of the combination of NPH and ultralente insulins taken at bedtime, and his blood glucose levels often dropped by 50-80 mg/dl through the night. The fear of nocturnal hypoglycemia and the patient's inability to control postprandial blood glucose levels were very frustrating to him. He had no evidence of microvascular complications. His blood pressure and lipids have always been within the normal range.

R.F.'s basal insulin regimen was changed to detemir insulin twice daily, and he was also given an insulin-to-carbohydrate ratio to determine lispro doses at mealtimes and a correction scale to aggressively correct hyperglycemia. He also received intensive diabetes education. By 7 April 2007, his A1C was 7.8%, and he had gained much more confidence as his blood . . . [Full Text of this Article]

	QUESTIONS

 

	COMMENTARY

 

	CLINICAL PEARLS

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?